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ABSTRACT 
The c yt ok in e i n t e r l e u k i n - 1 plays an important r o l e i n the i n d u c t i o n of IL-2 
s e c r e t i o n and IL-2 receptor expression. The events that f o l l o w b i n d i n g of IL-1 to 
i t s receptor are not known. We found that i n a p u r i f i e d T c e l l p o p u l a t i o n 
(comprising the L y t 2 " and L 3T 4" T c e l l s ) IL-1 i n the absence of antigen or mitogen 
induced strong p r o l i f e r a t i o n and de novo expression of IL-2R l i g h t c hain mRNA. 
This was accompanied by high a f f i n i t y IL-2 bin d i n g . Production of IL-2 or IL-2 
mRNA was not detected under these c o n d i t i o n s . As a model system f o r IL-1 a c t i o n 
two EL4 subclones were i s o l a t e d . EL4 5D3 responded to IL-1 by augmentation of PMA 
induced IL-2 s e c r e t i o n and IL-2R expression. EL4D6/76 bound IL-1 w i t h the same 
a f f i n i t y but d i d not respond. We found th a t t h i s l i n e was unable to i n t e r n a l i z e 
surface bound I L - 1 . The f i n d i n g suggests that i n T c e l l s i n t e r n a l i z a t i o n of IL-1 
i s r e q u i r e d f o r i t s a c t i v i t y . 
INTRODUCTION 
I n t e r l e u k i n - 1 (IL-1) exerts two main e f f e c t s on T c e l l s . Together w i t h mitogen or 
antigen i t induces the s e c r e t i o n of i n t e r l e u k i n - 2 (IL-2) (1) and the expression 
of IL-2 receptors (IL-2R)(2). When mouse thymocytes were st i m u l a t e d w i t h IL-1 i n 
the absence of added mitogen or antigen expression of IL-2R was observed(3). This 
e f f e c t was only seen i n the presence of IL-2 and was determined by bin d i n g of a 
monoclonal antibody a g a i n s t the IL-2R and by p r o l i f e r a t i o n . We concluded from 
these experiments th a t i n the absence of mitogen or antigen IL-1 induces only 
expression of IL-2R and no IL-2 s e c r e t i o n . To o b t a i n i n s i g h t i n t o the mechanism 
of these phenomena we attempted 1. to i d e n t i f y a p u r i f i e d t a r g e t c e l l p o p u lation 
f o r t h i s e f f e c t , and 2. to e s t a b l i s h a model system to be able t o study the 
mechanism on a biochemical and molecular l e v e l . 
A subpopulation of L y t 2 " and L 3T 4" thymocytes (DNT) s t r o n g l y responded to the 
combination of both cytokines i n a s y n e r g i s t i c f a s h i o n . We found t h a t the main 
e f f e c t of IL-1 was to st i m u l a t e de novo expression of hi g h a f f i n i t y IL-2R. Since 
the murine thymoma EL4 can respond to IL-1 by augmentation of IL-2 s e c r e t i o n and 
IL-2R expression (4) we subcloned EL4 and s e l e c t e d two subclones t h a t d i f f e r e d i n 
responsiveness to IL-1 w i t h respect to both p r o p e r t i e s . Using clones we show that 
i n t e r n a l i z a t i o n of IL-1 c o r r e l a t e s w i t h IL-1 a c t i v i t y . 
MATERIALS AND METHODS. 
C e l l C u l t u r e s : C e l l s were c u l t u r e d i n RPMI 1640 c o n t a i n i n g 52 FCS and 50 /*l/ml 
gentamycin a t 37°C i n a h u m i d i f i e d atmosphere of 52 C0 2 i n a i r . Thymocytes had 102 
FCS and 3xlO _ 5M 2-mercaptoethanol i n a d d i t i o n . 
P r e p a r a t i o n of DNT: DNT were prepared from thymuses of 4-week o l d C3H mice by 
antibody and complement treatment (5).The mixture i n c l u d e d a n t i b o d i e s against the 
antigens L 3T 4, L y t 2 , I a k , and MAC-1. The y i e l d was 11 of t o t a l thymic c e l l s They 
were 80-902 Thy-1 p o s i t i v e and 45-502 IL-2R p o s i t i v e . 
P r o l i f e r a t i o n Assays: P r o l i f e r a t i o n was assessed by using standard methods as 
described ( 5 ) . 
Recombinant Cytokines: Human (hu) r I L - l o was k i n d l y provided by Drs. A. Stern and 
P. Lomedico, Hoffmann-LaRoche, Nutley, NJ , USA. The s p e c i f i c a c t i v i t y was 
5xl06TJ/mg p r o t e i n determined by the lymphocyte a c t i v a t i n g f a c t o r assay. P u r i f i e d 
human recombinant IL-2 from E. c o l i was k i n d l y s u p p l i e d by Cetus Corporation, 
E m e r y v i l l e , USA. 
Assay f o r IL-2 Receptor Expression: A f f i n i t y p u r i f i e d mab 7D4 (6) was 
r a d i o i o d i n a t e d using the chloramin T method. C e l l s were washed and resuspended i n 
90 pi b i n d i n g medium (RPMI 1640, 0.006M Hepes, IX BSA, 0.12 Na-Azide). mab 7D4 
was added i n 10 / i l b i n d i n g medium to a f i n a l c o n c e n t r a t i o n of 4 pg/ml. Bound 
r e a d i o a c t i v i t y was determined as described ( 7 ) . 
RNA E x t r a c t i o n and H y b r i d i z a t i o n Procedures: Cytoplasmic RNA was prepared by the 
method of Cheley and Anderson ( 8 ) . RNA f o r Northern a n a l y s i s was prepared by the 
guanidine-isothiocyanate/cesiumchloride method. H y b r i d i z a t i o n s were done i n the 
presence of dextran sulphate and formamide at 42°C. The probe f o r the mouse IL-2 
was generously provided by Dr. A. Schimpl (Würzburg, FRG) and contains the 
complete exon 4 of the IL-2 gene ( 9 ) . The probe f o r the mouse IL-2R was 
generously provided by Dr. T. Malek (Miami, FL, USA). I t represents the EcoRI-
P s t l fragment of the IL-2R cDNA (clone pmIL-2prl) (10). 
I o d i n a t i o n of hu r I L - l a : P u r i f i e d hu r I L - l a was l a b e l e d w i t h 1 2 5 I by u t i l i z i n g the 
Enzymobead reagent according to the manufacturer's i n s t r u c t i o n s (BioRad Richmond, 
CA). B i o l o g i c a l a c t i v i t y of the i o d i n a t e d m a t e r i a l was 80 to 902 of the o r i g i n a l 
m a t e r i a l (data not shown). 
Binding of Labeled Cytokines to C e l l s : C e l l s were washed and incubated w i t h 
l a b e l e d cytokines as described ( 5 ) . T c e l l s were incubated f o r 2h at 37°C i n 
f r e s h medium p r i o r to b i n d i n g . 1 2 5 I - I L - 2 was purchased from NEN (NEX 229, 
D r e i e i c h , FRG) or Amersham (IM 197, F r a n k f u r t , FRG). The binding r e a c t i o n was 
terminated by c e n t r i f u g i n g the c e l l s through an o i l mixture. S p e c i f i c binding i s 
represented as the d i f f e r e n c e i n cpm bound by c e l l s w i t h and without nonlabeled 
c y t o k i n e . 
I n t e r n a l i z a t i o n of 1 2 5 I - r I L - l a : 4 x l 0 6 c e l l s and 8 U of 1 2 5 I - r I L - l o were preincubated 
i n 500 pi RPMI 1640 c o n t a i n i n g 52 FCS at 8°C f o r 1 h and then t r a n s f e r r e d to 37°C. 
Samples were removed at the i n d i c a t e d times. C e l l s were p e l l e t e d by 
c e n t r i f u g a t i o n and resuspended i n 500 pi pH 3 buffered medium. A f t e r i n c u b a t i o n 
on i c e f o r 5 min to remove surface bound r a d i o a c t i v i t y c e l l s were c e n t r i f u g e d 
again and l y s e d i n 200 plA l y s i s b u f f e r (10 mM T r i s HCl, pH 7.4; 150 mM NaCl; IX 
T r i t o n X-114; 2mM PMSF; 22 Isopropanol). A f t e r 10 min i n c u b a t i o n on i c e the 
nuclear and cytoplasmic f r a c t i o n s were separated by c e n t r i f u g a t i o n a t lOOOOxg at 
8°C f o r 10 min. R a d i o a c t i v i t y was determined i n a gamma counter. 
RESULTS AND DISCUSSION 
We were prompted to i n v e s t i g a t e DNT f o r a IL-1 response i n the absence of mitogen 
or antigen because i t was published t h a t DNT c a r r y receptors f o r IL-1 and respond 
to IL-1 i n the presence of mitogens (11). We knew from our previous experiments 
that there was a low percentage of IL-l-responder c e l l s among thymocytes. 
Therefore, DNT were prepared from thymuses of a d u l t mice and t e s t e d f o r a 
s y n e r g i s t i c response to the combination of IL-1 and IL-2. I t was shown that the 
s y n e r g i s t i c e f f e c t i n the presence of s a t u r a t i n g concentrations of IL-2 was IL-1 -
dose dependent ( 5 ) . N e i t h e r IL-1 nor IL-2 alone had any e f f e c t on growth. 
In other experiments (not shown) we showed that, the p r o l i f e r a t i v e response was 
dependent on IL-2 (the response was i n h i b i t e d t o 902 by mab again s t the IL-2R) 
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Figure I i Kinetics of IL-2 and IL-2R mRNA. DNT were c u l t u r e d w i t h IL-1 (10 U/ml) 
and IL-2 (50 U/ml) f o r 1 to 3 days. Cytoplasmic RNA from such c e l l s was b l o t t e d 
i n s e r i a l twofold d i l u t i o n s and probed w i t h probes f o r the l i g h t c hain of the IL-
2R and IL-2. The l e f t panel of F i g . 2 shows that there was r e l a t i v e l y l i t t l e I L -
2R mRNA on day 0 (lane 3 ) , no detectable mRNA on day 1 (lane 4) and d r a m a t i c a l l y 
i n c r e a s i n g amounts on days 2 and 3 (lanes 5 and 6). 
and t h a t t h i s i n h i b i t i o n was counteracted by IL-1 ( 5 ) . I t was a l s o shown that an 
18h pulse w i t h IL-1 was s u f f i c i e n t to induce maximal p r o l i f e r a t i o n suggesting a 
d i f f e r e n t i a t i o n s i g n a l given by IL - 1 . ( 5 ) . These data l e d t o the c o n c l u s i o n that 
IL-1 only s t i m u l a t e d IL-2R expression but not IL-2 s e c r e t i o n i n DNT. This 
hypothesis was confirmed on the mRNA l e v e l and by IL-2 b i n d i n g . 
The c o n t r o l s i n c l u d e d i n the dot b l o t were RNA from an IL-2-dependent c e l l l i n e 
(lane 1 ) , RNA from PMA stim u l a t e d EL4 (lane 2 ) , and RNA from the stimulat e d 
macrophage c e l l l i n e P388 D l (lane 7). The r i g h t panel of Fig.2 shows that IL-2 
mRNA under these c o n d i t i o n s was undetectable i n DNT. This f i n d i n g was 
corroborated by the binding of 1 2 5 I - I L - 2 under high a f f i n i t y c o n d i t i o n s . DNT were 
c u l t u r e d i n IL-1 plus IL-2 f o r 4 days and each an a l i q u o t was removed f o r 
bin d i n g . 6 x l 0 5 c e l l s per assay w e l l were incubated i n 20nM 1 2 5 I - I L - 2 and the 
amount of r a d i o a c t i v i t y bound was determined. IL-2 b i n d i n g e x a c t l y f o l l o w e d the 
pa t t e r n of IL-2R mRNA expression. S p e c i f i c cpm bound on days 0, 1, 2, and 3 were 
1501, 132, 2712, and 3482, r e s p e c t i v e l y . Scatchard a n a l y s i s performed on day 3 of 
c u l t u r e showed t h a t the IL-1 induced de novo expressed receptor was of high 
a f f i n i t y (K D 23 to 38 pM) (5) . We concluded from these experiments t h a t IL-1 i n 
the absence of mitogens only stimulates h i g h a f f i n i t y IL-2R expression. For the 
se c r e t i o n of IL-2 by T c e l l s a second s i g n a l l i k e a mitogen i s r e q u i r e d . I n our 
experimental system i t might be p o s s i b l e that a second s i g n a l f o r IL-2R 
expression i s provided by IL-2. I t i s known that IL-2 upregulates i t s own 
receptor ( 1 2 ) . I t was impossible i n our system to study the e f f e c t of e i t h e r 
cytokine alone since the c e l l s d i d not sur v i v e without IL-2. Whether the p75 
chain of the IL-2R was a l s o regulated cannot be answered by our experiments. 
There i s good evidence, however, f o r the i t s c o n s t i t u t i v e expression 
thymocytes(13). 
The mechanism of a c t i o n of IL-1 i n T c e l l s i s not known. L i k e other growth 
f a c t o r s IL-1 i s r a p i d l y i n t e r n a l i z e d (14). To study e a r l y events i n IL-1 
t r i g g e r e d T c e l l responses we cloned by l i m i t i n g d i l u t i o n two EL4 c e l l l i n e s that 
d i f f e r e d i n t h e i r IL-1 response. EL4 5D3 responded to IL-1 w i t h augmentation of 
IL-2 s e c r e t i o n and IL-2R expression whereas EL4D6/76 d i d not respond to IL- 1 . 
C e l l s of both l i n e s were sti m u l a t e d at 10 6/ml w i t h PMA (10ng/ml) and PMA plus I L -
1 (10U/ml). A f t e r 24h of c u l t u r e IL-2 t i t e r s were measured i n the supernatant and 
IL-2R expression on the c e l l s was determined. In EL4 5D3 IL-1 augmented IL-2R 
expression (measured by binding of l a b e l e d 7D4 anti-IL-2R antibody) by a f a c t o r 
of 5.8 and IL-2 s e c r e t i o n by 3.2. These numbers v a r i e d between experiments (range 
2-10). No I L - l - i n d u c e d increase i n both parameters was observed i n EL4D6/76. Both 
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l i n e s produced comparable amounts of IL-2 (220 U/ml versus 130 U/ml when 
stim u l a t e d w i t h PMA) and bound a comparable amount of antibody (1.300 cpm/105 
c e l l s versus 1.929 cpm). I t was shown before t h a t IL-1 binds to s p e c i f i c c e l l 
surface receptors (15). The most obvious e x p l a n a t i o n , t h e r e f o r e , f o r t h i s 
observed l a c k of IL-1 responsiveness of clone EL4D6/76 was a missing IL-1R on 
t h i s c e l l . This question was i n v e s t i g a t e d by determining number and a f f i n i t y of 
IL-1R on both clones by e v a l u a t i o n of Scatchard p l o t s of 1 2 5 I - I L - 1 binding to 
c e l l s . I t was found th a t EL4D6/76 and EL4 5D3 expressed 2300 to 2400 c e l l surface 
IL-1 receptors per c e l l , w i t h an apparent d i s s o c i a t i o n constant i n the range of 
1.2 -2.5xlO" 1 0M. This d i s s o c i a t i o n constant i s i n good agreement w i t h the data 
published f o r EL4 by K i l i a n et a l . (16). A l s o , no d i f f e r e n c e s were found i n 
a f f i n i t y c r o s s - l i n k i n g experiments w i t h 1 2 5 I - I L - 1 ( 7 ) . Both clones showed a band 
at 80 - 85 kD which i s c o n s i s t e n t w i t h published data (17). 
M i z e l et a l . (14) have shown that l a b e l e d IL-1 i s transported t o the nucleus i n 
EL4 and Swiss 3T3 c e l l s . To t e s t the p o s s i b i l i t y that EL4D6/76 might have l o s t 
the c a p a c i t y to i n t e r n a l i z e I L - 1 , we monitored the uptake of 1 2 5 I - r I L - l a by these 
c e l l s over a time p e r i o d of 6 h. 
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Figure.2t Kinetics of internalization of IL-1. R a d i o a c t i v i t y accumulated i n the 
cytoplasmic f r a c t i o n of EL4 5D3 c e l l s and reached a pla t e a u a f t e r 3 to 4 h. In 
co n t r a s t , there was no s i g n i f i c a n t increase of r a d i o a c t i v i t y i n the corresponding 
cytoplasmic f r a c t i o n of EL4D6/76. 
When the same experiment was c a r r i e d out i n the presence of PMA. no q u a l i t a t i v e 
d i f f e r e n c e was detected. Thus, i n t e r n a l i z a t i o n of IL-1 c o r r e l a t e s w i t h i t s 
a c t i v i t y i n EL4 c e l l s . Whether i n t e r n a l i z a t i o n of IL-1 or i t s t r a n s p o r t to the 
cytoplasm and nucleus are necessary f o r a response of a c e l l to IL-1 i s not 
known. Nevertheless, t h i s hypothesis i s supported by our experiments showing that 
chloroquine (10/ig/ml) i n h i b i t e d IL-1 induced IL-2 s e c r e t i o n of EL4 5D3 c e l l s (5 x 
10 5/ml) by 40 to 70Z. I t might th e r e f o r e be p o s s i b l e that IL-1 has to rea c t w i t h 
a nuclear receptor as po s t u l a t e d by M i z e l et a l . (14). I f IL-1 does not i n f l u e n c e 
any p o s t t r a n s l a t i o n a l parameters what i s i t s a c t i v i t y ? A f i r s t i n d i c a t i o n was 
obtained from a a n a l y s i s of mRNA production f o r IL-2 and IL-2R. C e l l s were 
induced w i t h IL-1 and PMA or PMA alone f o r 24 and 48 h and cytoplasmic RNA 
ex t r a c t s were probed f o r IL-2 and IL-2R mRNA, r e s p e c t i v e l y . 
Together w i t h p r e l i m i n a r y data showing that the h a l f l i f e of IL-2 mRNA was not 
d i f f e r e n t when EL4 5D3 c e l l s were sti m u l a t e d w i t h PMA or PMA plus IL-1 we 
concluded t h a t the e f f e c t of IL-1 was most l i k e l y due to increased t r a n s c r i p t i o n 
of IL-2 and IL-2R genes. I t i s t o t a l l y unknown how IL-1 a f f e c t s gene 




Figure 3s Northern blot of stimulated EL4 5D3 c e l l s . A f t e r 24 h of i n d u c t i o n EL4 
5D3 showed a s i g n i f i c a n t amount of IL-2 s p e c i f i c mRNA induced by PMA (lane 1 ). 
This amount was g r e a t l y increased when IL-1 i n a d d i t i o n was present during 
s t i m u l a t i o n (lane 2 ) . The same was true f o r IL-2R mRNA (not shown). 
t r a n s c r i p t i o n w i l l be necessary t o c l a r i f y the pathway of IL-1 dependent 
a c t i v a t i o n of T c e l l s . 
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